Loading clinical trials...
Loading clinical trials...
This study compares the therapeutic effects of once-daily fluorometholone 0.1% versus twice-daily cyclosporine 0.05% after short-term fluorometholone induction treatment in dry eye disease.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Korea University Anam Hospital
Collaborators
NCT07463950 · Dry Eye Disease (DED)
NCT07396441 · Juvenile Open Angle Glaucoma, Dry Eye Disease (DED), and more
NCT06984549 · Dry Eye Disease (DED)
NCT06841471 · Dry Eye Disease (DED), Dry Eye, and more
NCT07268599 · Dry Eye Disease (DED)
Korea University Anam Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions